(Q41693586)

7 October 2017

title

Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children (English)

1 reference

7 October 2017

1 reference

Kemp JP

1

1 reference

7 October 2017

Skoner DP

2

1 reference

7 October 2017

Szefler SJ

3

1 reference

7 October 2017

Walton-Bowen K

4

1 reference

7 October 2017

Cruz-Rivera M

5

1 reference

7 October 2017

Smith JA

6

1 reference

7 October 2017

publication date

1 September 1999

1 reference

Annals of Allergy, Asthma & Immunology

7 October 2017

published in

1 reference

7 October 2017

volume

83

1 reference

7 October 2017

issue

3

1 reference

7 October 2017

page(s)

231-239

1 reference

Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Morbidity and mortality of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Changes in asthma prevalence: two surveys 15 years apart

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Inhaled budesonide for treatment of recurrent wheezing in early childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Use of budesonide in severe asthmatics aged 1-3 years

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Inhaled budesonide for chronic wheezing under 18 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Controlled trial of budesonide given by the nebuhaler in preschool children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Budesonide treatment of moderate and severe asthma in children: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Nebulised budesonide in severe infantile asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Dose titration of nebulized budesonide in young children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Nebulised sodium cromoglycate in recurrently wheezy preschool children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. A multicentre double-blind placebo controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Efficacy of cromoglycate in persistently wheezing infants

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962646-4

7 January 2021

10.1016/S1081-1206(10)62646-4

Identifiers

DOI

1 reference

7 October 2017

1 reference